At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
Outpatient MRIother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Developing an US-MRI Biomarker Fusion Model for Endometriosis (DEFEND)
In Brief
An observational study evaluating Outpatient MRI for Endometriosis and Reproductive System Disorder. Completed, enrolled 100 participants across 1 site.
Detailed Summary
Single centre, prospective, observational, cohort study looking to develop a database representing the variability of disease and imaging seen in women with clinically diagnosed endometriosis, awaiting laparoscopic surgery.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsEndometriosis, Reproductive System Disorder
CountriesUnited Kingdom
CollaboratorsGE Healthcare
Timeline
N/ACompletedFinished
20222023202420252026
First PostedJul 2021
Enrollment StartMar 2022
Primary CompletionMar 2023
TodayJul 2026
First PostedJul 23, 2021
Enrollment StartMar 18, 2022
Primary CompletionMar 31, 2023
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 4.9 years ago
Interventions
Outpatient MRIother
All participants will undergo a standardised imaging protocol in a MRI scanner. This will take place during the same visit or following the transvaginal ultrasound (TVUS) and in advance of any surgical procedure (laparoscopy).